| Financial Year |
March 31 2023 |
| Monetary Funds |
778,730,879.12 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
453,213,723.05 |
| Advances to Suppliers |
33,546,638.19 |
| Other Receivables |
10,171,427.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
786,347,580.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,087,236.18 |
| Total Current Assets |
2,352,090,790.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
93,504,260.99 |
| Investment Properties |
-- |
| Fixed Assetes |
1,530,054,163.39 |
| Under-construction Projects |
686,382,071.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
312,730,543.52 |
| R&D expenses |
11,293,526.62 |
| Goodwill |
404,959,974.18 |
| Long-Term Deferred and Prepaid Expenses |
20,892,834.93 |
| Deferred Income Tax Assets |
29,319,407.04 |
| Other Non-Current Assets |
39,340,506.18 |
| Sub-Total of Non-Current Assets |
3,171,159,831.93 |
| Total Assets |
5,523,250,622.47 |
| Short-Term Loans |
1,769,989,212.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
159,046,564.57 |
| Accounts Payable |
360,326,858.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,614,875.94 |
| Taxes Payable |
7,335,730.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,668,322.83 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
473,726,382.01 |
| Other Current Liabilities |
407,739.70 |
| Sub-Total of Current Liabilities |
2,869,824,660.78 |
| Long-term Loans |
770,123,919.35 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,260,339.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
872,648,071.70 |
| Total Liabilities |
3,742,472,732.48 |
| Paid-In Capital(Or Share Stock) |
342,914,439.00 |
| Capital Surplus |
813,793,484.49 |
| Surplus Reserve |
140,295,043.28 |
| LESS:Treasury Stock |
24,643,513.00 |
| Undistributed Profits |
493,520,831.23 |
| Minority Stockholder's Interest |
5,731,951.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,775,045,938.74 |
| Owner's Equity（Stockholder's Equity） |
1,780,777,889.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,523,250,622.47 |
